ACT UP NY has slammed a decision by the FDA to give market exclusivity for the drug Remdesivir to Gilead for seven years. Remdesivir is being used in COVID-19 clinical trials as it has been shown to be effective for COVID-19 patients.
Remdesivir was originally developed by Gilead to combat Ebola during the West African […] The post Gilead holding patent on an antiviral drug that shows promise for COVID-19 treatment appeared first on GCN.